SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc. – ‘S-1/A’ on 3/27/24 – ‘EX-23.1(A)’

On:  Wednesday, 3/27/24, at 4:43pm ET   ·   Accession #:  950170-24-37277   ·   File #:  333-276280

Previous ‘S-1’:  ‘S-1/A’ on 2/9/24   ·   Latest ‘S-1’:  This Filing   ·   41 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Biolase, Inc.                     S-1/A                  5:1.1M                                   Donnelley … Solutions/FA

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   1.01M 
                (General Form)                                                   
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     13K 
 3: EX-23.1(A)  Consent of Expert or Counsel                        HTML      6K 
 4: EX-23.1(B)  Consent of Expert or Counsel                        HTML      6K 
 5: EX-FILING FEES  Filing Fees                                     HTML     33K 


‘EX-23.1(A)’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-23.1(a)  

Exhibit 23.1(a)

Consent of Independent Registered Public Accounting Firm

BIOLASE, Inc.

Lake Forest, California

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 (File No. 333-276280) of our report dated March 21, 2024, relating to the consolidated financial statements and schedule listed in the index appearing under Item 15(a)(2), which appears in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

We also consent to the reference to our firm under the caption “Experts” in this Registration Statement on Form S-1.

/s/ Macias Gini & O’Connell, LLP

Macias, Gini & O’Connell, LLP

Irvine, California

March 27, 2024



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:3/27/24
3/21/2410-K,  8-K,  ARS,  DEF 14A,  DEFA14A
12/31/2310-K,  ARS
 List all Filings 


41 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/22/24  Biolase, Inc.                     DEF 14A     5/02/24    8:5M                                     Donnelley … Solutions/FA
 3/21/24  Biolase, Inc.                     10-K       12/31/23   99:18M                                    Donnelley … Solutions/FA
 3/05/24  Biolase, Inc.                     8-K:3       3/04/24   10:141K                                   Donnelley … Solutions/FA
 2/27/24  Biolase, Inc.                     8-K:8,9     2/26/24   10:140K                                   Donnelley … Solutions/FA
 2/21/24  Biolase, Inc.                     8-K:8       2/20/24   10:136K                                   Donnelley … Solutions/FA
 2/15/24  Biolase, Inc.                     8-K:1,3,8,9 2/12/24   20:1.3M                                   Donnelley … Solutions/FA
12/26/23  Biolase, Inc.                     S-1                    4:496K                                   Donnelley … Solutions/FA
12/08/23  Biolase, Inc.                     8-K:1,3,8,912/06/23   16:767K                                   Donnelley … Solutions/FA
 9/18/23  Biolase, Inc.                     8-K:1,3,5,8 9/13/23   16:887K                                   Donnelley … Solutions/FA
 8/30/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 7/26/23  Biolase, Inc.                     8-K:3,5,8,9 7/20/23   12:201K                                   Donnelley … Solutions/FA
 6/06/23  Biolase, Inc.                     8-K:3,5,8,9 6/05/23   12:225K                                   Donnelley … Solutions/FA
 5/26/23  Biolase, Inc.                     8-K:1,3,5,8 5/24/23   16:890K                                   Donnelley … Solutions/FA
 1/05/23  Biolase, Inc.                     8-K:1,9    12/30/22   11:1.3M                                   Donnelley … Solutions/FA
11/10/22  Biolase, Inc.                     10-Q        9/30/22   83:14M                                    Donnelley … Solutions/FA
 6/08/22  Biolase, Inc.                     8-K:3,5,7,9 6/08/22   12:10M                                    Donnelley … Solutions/FA
 5/02/22  Biolase, Inc.                     8-K:5,9     4/28/22   11:180K                                   Donnelley … Solutions/FA
 3/03/22  Biolase, Inc.                     8-K:3,5,7,9 3/01/22   13:359K                                   Donnelley … Solutions/FA
 3/03/22  Biolase, Inc.                     8-A12G                 2:46K                                    Donnelley … Solutions/FA
11/10/21  Biolase, Inc.                     10-Q        9/30/21   84:13M                                    Donnelley … Solutions/FA
 4/19/21  Biolase, Inc.                     DEF 14A     5/26/21    1:1.2M                                   Donnelley … Solutions/FA
 6/01/20  Biolase, Inc.                     8-K:5,9     5/28/20    2:26K                                    Donnelley … Solutions/FA
 5/08/20  Biolase, Inc.                     10-Q        3/31/20   86:8.5M                                   ActiveDisclosure/FA
 4/23/20  Biolase, Inc.                     DEF 14A     5/13/20    1:1.5M                                   ActiveDisclosure/FA
 3/30/20  Biolase, Inc.                     10-K       12/31/19   90:24M                                    ActiveDisclosure/FA
 9/05/19  Biolase, Inc.                     S-1         9/04/19    3:929K                                   Donnelley … Solutions/FA
 4/10/19  Biolase, Inc.                     DEF 14A     5/15/19    1:971K                                   Donnelley … Solutions/FA
11/14/18  Biolase, Inc.                     10-Q        9/30/18   81:11M                                    ActiveDisclosure/FA
 8/24/18  Biolase, Inc.                     DEF 14A     9/21/18    1:1.6M                                   Donnelley … Solutions/FA
 5/11/18  Biolase, Inc.                     8-K:5,9     5/10/18    2:26K                                    Donnelley … Solutions/FA
 4/05/18  Biolase, Inc.                     DEF 14A     5/09/18    1:717K                                   Donnelley … Solutions/FA
10/03/17  Biolase, Inc.                     8-K:5,7,8,9 9/30/17    4:90K                                    Donnelley Fi… Express/FA
 7/21/17  Biolase, Inc.                     S-3                    4:281K                                   ActiveDisclosure/FA
 4/07/16  Biolase, Inc.                     DEF 14A     5/06/16    1:1M                                     Donnelley … Solutions/FA
11/06/15  Biolase, Inc.                     10-Q        9/30/15   68:7.2M                                   ActiveDisclosure/FA
11/04/14  Biolase, Inc.                     8-A12B/A               3:38K                                    Donnelley … Solutions/FA
 5/16/12  Biolase, Inc.                     8-K:5,7,9   5/10/12    3:44K                                    Donnelley Fi… Express/FA
12/23/05  Biolase, Inc.                     S-1/A                  6:2.3M                                   Donnelley … Solutions/FA
11/09/05  Biolase, Inc.                     10-Q        9/30/05    9:771K                                   Donnelley … Solutions/FA
 7/19/05  Biolase, Inc.                     10-K       12/31/04   17:2.2M                                   Donnelley … Solutions/FA
 6/03/02  Biolase, Inc.                     S-3                    6:225K                                   Donnelley R R & S… 11/FA
Top
Filing Submission 0000950170-24-037277   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 12:58:20.2pm ET